Bariatric surgery (BS), recognized as the most effective intervention for morbid obesity and
associated metabolic comorbidities, encompasses both weight loss-dependent and weight …

Abstract Laparoscopic Gastric Plication (LGP) is a relatively new bariatric surgical procedure
which no part of the stomach is removed. It is not clearly understood how LGP leads to fatty …

Bariatric surgery is an effective treatment for morbid obesity with a sustained weight loss and
improvements in metabolic syndrome. We present a label free quantitative shotgun …

Objective Gastric bypass surgery results in long‐term weight loss. Small studies have
examined protein changes during rapid weight loss (up to 1 or 2 years post surgery). This …

Obesity-related diseases affect half of the global population, and bariatric surgery is one of
the few interventions with long-lasting weight loss and cardio-metabolic effects. Here, we …

Bariatric surgery (BS) results in metabolic pathway recalibration. We have identified
potential biomarkers in plasma of people achieving type 2 diabetes mellitus (T2DM) …

Severe obesity is a disease associated with multiple adverse effects on health. Metabolic
bariatric surgery (MBS) can have significant effects on multiple body systems and was …

Objective To characterize longitudinal changes in blood biomarkers, leukocyte composition,
and gene expression following laparoscopic sleeve gastrectomy (LSG). Background LSG is …

Background Laparoscopic sleeve gastrectomy (LSG) is a sustainable technique that
effectively treats morbid obesity. However, the molecular mechanisms underlying the …

This prospective observational study aimed to evaluate the association of metabolomic
alterations with weight loss outcomes following sleeve gastrectomy (SG). We evaluated the …